Alternaria alternata
Alternaria alternata has been studied in 2 papers since 2019: none in people yet, 1 in animals, 1 review; 1 in the past year. The research so far is in animals. The newest paper, Jan 30, 2026: “Intestinal probiotic fungi improve PCOS by sensing metformin signaling and inhibiting gut derived ceramide levels”.
2 papers study it2 findingsUpdated
See all 2 papers on alternaria alternata
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funders: National Natural Science Foundation of China and 1 more
- Animals1
What did studies of alternaria alternata find?
2Studies of alternaria alternata measured 2 outcomes: ovarian function and polycystic ovary syndrome.
Ovarian function
upin mice1
1 study
Ovarian function
upin mice1
Alternaria alternata improves ovarian function in mice (PCOS).
“reducing ceramide levels and endoplasmic reticulum stress in granulosa cells to improve ovarian function”
AnimalsPCOS
Research SquarePreprint
Polycystic ovary syndrome
downin mice1
1 study
Polycystic ovary syndrome
downin mice1
Alternaria alternata decreases polycystic ovary syndrome in mice (PCOS).
“Alternaria alternata (A. alternata) as a metformin-enriched gut fungus that alleviates PCOS in mice”
AnimalsPCOS
Research SquarePreprint